U.S. Markets closed

Array BioPharma Inc. (ARRY)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
8.24-0.14 (-1.67%)
At close: 4:00PM EDT
People also watch
Full screen
Previous Close8.38
Bid7.95 x 300
Ask8.35 x 200
Day's Range8.15 - 8.49
52 Week Range3.10 - 13.40
Avg. Volume3,437,179
Market Cap1.41B
PE Ratio (TTM)-11.44
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Zacks2 days ago

    New Strong Sell Stocks for July 20th

    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

  • American City Business Journals4 days ago

    Colorado biotech makes deal with industry giant

    A Boulder biotech said it's made a deal with an industry giant to develop drugs for autoimmune disorders. Array BioPharma Inc. (ARRY) said it's made a deal with giant Amgen Inc. (AMGN) of Thousand Oaks, California to take advantage of Array's inflammatory disease discoveries. "The identification of this novel target, along with our team's deep experience in kinase inhibitor chemistry, gives us confidence that our efforts will result in a drug which will address a significant unmet medical need for patients with inflammatory disease," said Nicholas Saccomano, chief scientific officer at Array, in a statement.

  • Capital Cube9 days ago

    ETFs with exposure to Array BioPharma, Inc. : July 12, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Array BioPharma, Inc. Here are 5 ETFs with the largest exposure to ARRY-US. Comparing the performance and risk of Array BioPharma, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)